(Q36108506)

12 August 2017

10 references

13 March 2019

14 March 2019

22 March 2019

24 March 2019

17 June 2019

20 June 2019

27 October 2020

5 December 2020

4 February 2021

26 October 2022

Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance (English)

1 reference

peripheral artery disease

12 August 2017

cardiovascular disease

7 references

13 March 2019

14 March 2019

22 March 2019

24 March 2019

17 June 2019

20 June 2019

27 October 2020

7 references

13 March 2019

14 March 2019

22 March 2019

24 March 2019

17 June 2019

20 June 2019

27 October 2020

7 references

13 March 2019

14 March 2019

22 March 2019

24 March 2019

17 June 2019

20 June 2019

27 October 2020

3 references

27 October 2020

4 February 2021

anti-diabetic medication

1 reference

27 October 2020

1 reference

5 December 2020

1 reference

Kazunori Utsunomiya

1

1 reference

PMCID

3402056

12 August 2017

language of work or name

English

0 references

publication date

4 July 2012

11 references

Vascular Health and Risk Management

12 August 2017

13 March 2019

14 March 2019

22 March 2019

24 March 2019

17 June 2019

20 June 2019

27 October 2020

5 December 2020

4 February 2021

26 October 2022

11 references

12 August 2017

13 March 2019

14 March 2019

22 March 2019

24 March 2019

17 June 2019

20 June 2019

27 October 2020

5 December 2020

4 February 2021

26 October 2022

8

1 reference

12 August 2017

429-436

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

12 August 2017

start time

1 July 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Insulin resistance: the link between obesity and cardiovascular disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Prostacyclin in vascular diseases. - Recent insights and future perspectives -.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

10-year follow-up of intensive glucose control in type 2 diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Insulin signaling to the glomerular podocyte is critical for normal kidney function

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402056

Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group

23 September 2018

1 reference

12 December 2020

Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease

1 reference

12 December 2020

Peripheral arterial disease, chronic kidney disease, and mortality: the Chinese Ankle Brachial Index Cohort Study

1 reference

12 December 2020

Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle

1 reference

12 December 2020

Identifiers

DOI

10.2147/VHRM.S32357

1 reference

release_opkfz3q6irbyjnqxkqheyahkam

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/opkfz3q6irbyjnqxkqheyahkam

24 November 2022

mapped directly with Wikidata item

PMCID

3402056

1 reference

12 August 2017

1 reference

PMCID

3402056